Antagonism of CRTH2 ameliorates chronic epicutaneous sensitization-induced inflammation by multiple mechanisms

被引:25
作者
Boehme, Stefen A. [1 ]
Chen, Edward P. [1 ]
Franz-Bacon, Karin [1 ]
Sasik, Roman [2 ,3 ]
Sprague, L. James [2 ]
Ly, Tai Wei [1 ]
Hardiman, Gary [2 ,4 ]
Bacon, Kevin B. [1 ]
机构
[1] Actimis Pharmaceut Inc, San Diego, CA 92121 USA
[2] Univ Calif La Jolla, Biomed Genom Microarray Facil BIOGEM, Sch Med, San Diego, CA USA
[3] Univ Calif La Jolla, Moores Canc Ctr, San Diego, CA USA
[4] Univ Calif La Jolla, Dept Med, San Diego, CA USA
基金
美国国家卫生研究院;
关键词
PROSTAGLANDIN D-2; ATOPIC-DERMATITIS; TH2; CELLS; ALLERGIC INFLAMMATION; PROINFLAMMATORY CYTOKINES; DIFFERENTIAL EXPRESSION; CORNIFIED ENVELOPE; ANTIGEN CHALLENGE; EPITHELIAL-CELLS; RECEPTOR CRTH2;
D O I
10.1093/intimm/dxn118
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Prostaglandin D-2 (PGD(2)) and its receptor chemoattractant receptor homologous molecule expressed on T(h)2 cells (CRTH2) have been implicated in the pathogenesis of numerous allergic diseases. We investigated the role of PGD(2) and CRTH2 in allergic cutaneous inflammation by using a highly potent and specific antagonist of CRTH2. Administration of this antagonist ameliorated cutaneous inflammation caused by either repeated epicutaneous ovalbumin or FITC sensitization. Gene expression and ELISA analysis revealed that there was reduced pro-inflammatory cytokine mRNA or protein produced. Importantly, the CRTH2 antagonist reduced total IgE, as well as antigen-specific IgE, IgG1 and IgG2a antibody levels. This reduction in antibody production correlated to reduced cytokines produced by splenocytes following in vitro antigen challenge. An examination of skin CD11c(+) dendritic cells (DC) showed that in mice treated with the CRTH2 antagonist, there was a decrease in the number of these cells that migrated to the draining lymph nodes in response to FITC application to the skin. Additionally, naive CD4(+) T lymphocytes co-cultured with skin-derived DC from CRTH2 antagonist-treated mice showed a reduced ability to produce a number of cytokines compared with DC from vehicle-treated mice. Collectively, these findings suggest that CRTH2 has a pivotal role in mediating the inflammation and the underlying immune response following epicutaneous sensitization.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 43 条
[1]  
BELLRANI VS, 1999, J ALLERGY CLIN IMMUN, V104, pS87
[2]  
Boehme SA, 1999, J IMMUNOL, V163, P1611
[3]  
CAMPBELL JJ, 2005, EXP DERMATOL, V14, P76
[4]   CXCR2 ligands and G-CSF mediate PKCα-induced intraepidermal inflammation [J].
Cataisson, Christophe ;
Pearson, Andrea J. ;
Tsien, Margaret Z. ;
Mascia, Francesca ;
Gao, Ji-Liang ;
Pastore, Saveria ;
Yuspa, Stuart H. .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (10) :2757-2766
[5]   Cutting edge: Chemoattractant receptor-homologous molecule expressed on TH2 cells plays a restricting role on IL-5 production and eosinophil recruitment [J].
Chevalier, E ;
Stock, J ;
Fisher, T ;
Dupont, M ;
Fric, M ;
Fargeau, H ;
Leport, M ;
Soler, S ;
Fabien, S ;
Pruniaux, MP ;
Fink, M ;
Bertrand, CP ;
McNeish, J ;
Li, BY .
JOURNAL OF IMMUNOLOGY, 2005, 175 (04) :2056-2060
[6]   Controlling false-negative errors in microarray differential expression analysis: a PRIM approach [J].
Cole, SW ;
Galic, Z ;
Zack, JA .
BIOINFORMATICS, 2003, 19 (14) :1808-1816
[7]   The immunogenetics of asthma and eczema: A new focus on the epithelium [J].
Cookson, W .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (12) :978-988
[8]   The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions [J].
Flier, J ;
Boorsma, DM ;
Bruynzeel, DP ;
van Beek, PJ ;
Stoof, TJ ;
Scheper, RJ ;
Willemze, R ;
Tensen, CP .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (04) :574-578
[9]   Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice [J].
Fujitani, Y ;
Kanaoka, Y ;
Aritake, K ;
Uodome, N ;
Okazaki-Hatake, K ;
Urade, Y .
JOURNAL OF IMMUNOLOGY, 2002, 168 (01) :443-449
[10]   EPIDERMAL AND DERMAL DISTRIBUTION OF A MYELOMONOCYTIC ANTIGEN (L1) SHARED BY EPITHELIAL-CELLS IN VARIOUS INFLAMMATORY SKIN DISEASES [J].
GABRIELSEN, TO ;
DALE, I ;
BRANDTZAEG, P ;
HOEL, PS ;
FAGERHOL, MK ;
LARSEN, TE ;
THUNE, PO .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 15 (02) :173-179